31DEC

Welcome To Mediterr J Med Res

Manuscripts are accepted for consideration with understanding that they are represent original material and they are not being considered for publication elsewhere. The editors welcome the submission of relevant articles for editorial consideration. Manuscripts and all scientific and professional data should be addressed to Editor-in-Cheif (Fmosherif@yahoo.com).

Mediterranean Journal of Medical Research
http://www.mjpe.periodikos.com.br/article/doi/10.5281/zenodo.17507103

Mediterranean Journal of Medical Research

Original article

Pharmacological evaluation of the effects of aqueous nut extract of Cyperus esculentus (Tiger nut) on convulsive episodes and anxiety-like behaviors in mice

Love Enebeli, Adedotun David Soremekun, Blessing Oluwafemi Ajiboye, Favour Boluwatife Jegede, Clinton Ijirigho, Benneth Ben-Azu, Abayomi M. Ajayi, Solomon Umukoro

Downloads: 1
Views: 98

Abstract

Patients with convulsive disease exhibit disorders as anxiety, which further impairs their quality of life and productivity. Despite the availability of anticonvulsant drugs, most patients in Africa for several reasons, still depend largely on herbal medicines as alternative forms of therapy for epilepsy. This study investigates the effect of the aqueous extract of Cyperus esculentus (tiger nut) on convulsive episodes and anxiety-like behaviors in mice. Male mice were pretreated orally with the extract (50, 100, and 200 mg/kg), diazepam (1.0 mg/kg), 30 min before induction of convulsions with pentylenetetrazole (100 mg/kg) or isoniazid (300 mg/kg). The mice were then observed for the onset of convulsions for 30 min for pentylenetetrazole, and two hours for isoniazid. A new set of mice was divided into five groups and was given diazepam and the extract (50-200 mg/kg). Thirty minutes later, the mice were evaluated for anxiety-like behaviors. The extract exhibited protective effect against convulsions induced by pentylenetetrazole at doses of 50 and 100 mg/kg, and against isoniazid at 50 mg/kg as evidenced by increased latency to sezuires and reduced number of mice that had convulsions. The extract also demonstrated anxiolytic-like activity in the light/dark box and elevated plus maze tests when compared with the controls. These findings suggest that C. esculentus exhibited anticonvulsant and anxiolytic-like activities in mice, and might be relevance in improving the quality of life of persons compromised by epilepsy.

Keywords

Anticonvulsant, anxiolytic-like effect, Cyperus esculentus, isoniazid, pentylenetetrazole

References

  1. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, Engel J Jr. Epileptic seizures and epilepsy: Definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005; 46(4): 470-472. doi: 10.1111/j.0013-9580.2005.66104.x
  2. Raimondo JV, Burman R J, Katz AA, Akerman CJ. Ion dynamics during seizures. Frontiers in Cellular Neurosciences. 2015; 9: 419. doi: 10.3389/fncel.2015.00419
  3. Matsuoka H. Neuropsychology of epilepsy. Epilepsia. 200; (42: 6): 42-646. PMID: 11902322.
  4. Werner FM, Covesnas R. Classical neurotransmitters and neuropeptides involved in generalized epilepsy: A focus on antiepileptic drugs. Current Medicinal Chemistry. 2011; 18: 4933-4948. doi: 10.2174/092986711797535191
  5. Yin HY, Ahmad N, Makmor-Bakry M. Pathogenesis of epilepsy: Challenges in animal models. Iranian Journal of Basic Medical Sciences. 2013; 16: 1119-1132. PMID: 24494063; PMCID: PMC3909622.
  6. Aroniadou-Anderjaska V, Fristch B, Qashu F, Braga MF. Pathology and pathophysiology of the amygdala in epileptogenesis and epilepsy. Epilepsy Research. 2008; 78: 102-116.  doi: 10.1016/j.eplepsyres.2007.11.011
  7. Ngugi AK, Bottomley C, Kleinschmidt I, Wagner RG. Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated factors: cross-sectional and case-control studies. Lacent Neurology. 2013; 12: 253-263. doi: 10.1016/S1474-4422(13)70003-6
  8. Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CP. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia. 2010; 51: 883-890.  doi: 10.1111/j.1528-1167.2009.02481.x
  9. Owolabi LF, Owolabi SD, Taura AA, Ibrahim D, Ogunniyi A. Prevalence and burden of epilepsy in Nigeria: A systematic review and meta-analysis of community-based door-to-door surveys. Epilepsy and Behavior. 2019; 92: 226-234. doi: 10.1016/j.yebeh.2018.12.017
  10. Scott AJ, Sharpe L, Hunt C, Gandy M. Anxiety and depressive disorders in people with epilepsy: A meta-analysis. Epilepsia. 2017; 58: 973-982. doi: 10.1111/epi.13769
  11. White HS. Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs. Epilepsia. 1997; 38: S9-S17. doi: 10.1111/j.1528-1157.1997.tb04523.x
  12. López-Gómez M, Espinola M, Ramirez-Bermudez J, Martinez-Juarez IE, Sosa AL. Clinical presentation of anxiety among patients with epilepsy. Neuropsychiatric Disease and Treatment. 2008; 4: 1235-1239. doi: 10.2147/ndt.s 3990
  13. Dehn LB, Pfäfflin M, Brückner S, Lutz MT, Steinhoff BJ, Mayer T, et al. Relationships of depression and anxiety symptoms with seizure frequency: Results from a multicenter follow-up study. Seizure. 2017; 53: 103-109. doi: 10.1016/j.seizure.2017.11.008
  14. Newsom-Davis I, Goldstein LH, Fitzpatrick D. Fear of seizures: An investigation and treatment. Seizure. 1988; 7(2): 101-116. PMID: 9627199.
  15. Gandy M, Sharpe L, Perry KN. Psychosocial predictors of depression and anxiety in patients with epilepsy: A systematic review. Journal of Affective Disorders. 2012; 140: 222-232. doi: 10.1016/j.jad.2011.11.039
  16. Achoribo ES, Ong MT. Tiger nut (Cyperus esculentus): source of natural anticancer drug? Brief review of existing literature. Euromediterranean Biomedical Journal. 2017; 12: 91-94. doi: 10.3269/1970-5492.2017.12.19
  17. Ogbeide OK, Jackson-Akpamu CO, Akhidenor DO. Characterization, physicochemical analysis, and antimicrobial activity of a cream from oil extracted from Cyperus esculentus l. (tiger nuts). Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2025; 5(2): 49-61. doi: 10.5281/zenodo.15225961
  18. Maduka N, Ire FS. Tiger nut plant and useful application of tiger nut Tubers (Cyperus esculentus)-a review. Current Journal of Applied Science and Technology. 2018; 29: 1-23. doi. 10.1016/j.fochx.2023.100868
  19. Allouh MZ, Daradka HM, Ghaida JH. Influence of Cyperus esculentus tubers (Tiger Nut) on male rat copulatory behavior. BMC Complementary Medicine and Therapies. 2015; 15: 331. doi: 10.1186/s12906-015-0851-9
  20. Gambo A, Da’u A. Tiger nut (Cyperus esculentus): composition, products, uses and health benefits-a review. Bayero Journal of Pure and Applied Science. 2004; 7: 56-61. doi: 10.4314/bajopas.v7i1.11
  21. Adejuyitan JA. Tiger nut processing: its food uses and health benefits. American Journal of Food Technology. 2011; 6: 197-201. doi: 10.3923/ajft.2011.197.201
  22. Mohamed LS, Mohsen Z, Imaizumi K. Dietary supplementation with Cyperus esculentus L (tiger nut) tubers attenuated atherosclerotic lesion in apolipoprotein E knockout mouse associated with inhibition of inflammatory cell responses. American Journal of Immunology. 2005; 1: 60-67. doi: 10.3844/ajisp.2005.60.67.
  23. Oyedepo TA, Odoje OF. Hepato-protective activities of tiger nut (Cyperus esculentus) against hepatotoxicity induced by carbon tetrachloride in rats. Research and Reviews Journal of Pharmacology and Toxicological Studies. 2014; 2: 2322-2339. Corpus ID: 56151385.
  24. Ogunlade I, Adeyemi BA, Aluko OG. Chemical compositions, antioxidant capacity of Tiger nut (Cyperus esculentus) and potential health benefits. European Scientific Journal. 2015; 11: 217-224. doi: Nil.
  25. Zommara M, Imaizumi K. Antiatherogenic effect of tiger nut tubers (Cyperus lentus L.) supplemented diet in apolipoprotein E knockout mice. Journal of Sustainable Agricultural Sciences. 2018; 43: 197-204. doi: 10.21608/ jsas.2018.1942.1031
  26. Umukoro S, Okoh L, Igweze CS, Ajayi AM, Ben-Azu, B. Protective effect of Cyperus esculentus (Tiger nut) extract against scopolamine-induced memory loss and oxidative stress in mouse brain. Drug Metabolism and Personalized Therapy. 2020; 35(3): 20200112. doi: 10.1515/dmpt-2020-0112
  27. Monago CC, Uwakwe AA. Proximate composition and in-vitro anti-sickling property of Nigerian Cyperus esculentus (tiger nut sedge). Trees for Life Journal. 2009; 4: 1-6.
  28. Alhassan AW, John M, Saleh MIA, Yusuf A, Yarube IU. Evaluation of the protective effect of hydro-methanolic extract of tiger nut (Cyperus esculentus L.) on pentylenetetrazole induced seizures in mice. Nature and Science. 2016; 14(10): 57-62. doi: 10.7537/marsnsj141016.10
  29. Löscher W, Hönack D, Fassbender CP, Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs pentylenetetrazole seizure models. Epilepsy Research. 1991; 8: 171-189. doi: 10.1016/0920-1211(91)90062-k
  30. Corda MG, Costa E, Guidtti A. Specific proconvulsant action of an imidazobendiazepine (RO-15-1788) on isoniazid convulsions. Neuropharmacology. 1982; 21: 91-94. doi: 10.1016/0028-3908(82)90217-9
  31. Bourin M, Hascoet M. The mouse light/dark box test. European Journal of Pharmacology. 2003; 463: 55-65. doi: 10.1016/s0014-2999(03)01274-3
  32. Pellow S, Chopin P,  File ST, Briely B. Validation of open-closed arm entries in elevated plus maze as a measure of anxiety in the rat. Journal of Neuroscience Methods. 1985; 14: 149-167. doi: 10.1016/0165-0270(85)90031-7
  33. Sherif F, Oreland L. Effect of the GABA-transaminase inhibitor vigabatrin on exploratory behaviour in socially isolated rats. Behavioral Brain Research. 1995; 72(1-2): 135-40. doi: 10.1016/0166-4328(96)00047-2
  34. Rogawski MA, Porter RJ. Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacological Reviews. 1990; 42: 224-247. PMID: 2217531.
  35. Kendall DA, Fox DA, Enna SJ. Anticonvulsant profile of gamma vinyl GABA. Neuropharmacology. 1981; 20(4): 4-10. doi: 10.1016/0028-3908(81)90008-3
  36. Bazine HA, Shlak MA, Sherif FM. A neuropharmacological profile of lycium schweinfurthii (solanaceae) methanolic extract in mice. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2023; 3(1): 43-50. doi: 10.5281/zenodo.7771364
  37. Annafi OS, Umukoro S, Eduviere AT. Evaluation of the anticonvulsant and anxiolytic potentials of methyl jasmonate in mice. SCI Pharma. 2014; 82: 643-654. doi: 10.3797/scipharm.1310-22
  38. Bassin S, Smith TL, Bleck TP. Clinical review: Status epilepticus. Critical Care. 2002; 6: 137-142. doi: 10.1186/ cc1472
  39. Minns AB, Ghafouri N, Clark RF. Isoniazid-induced status epilepticus in a pediatric patient after inadequate pyridoxine therapy. Pediatric Emergency Care. 2010; 26: 380-381. doi: 10.1097/PEC.0b013e3181db24b6
  40. Puri MM, Kumar L, Vishwakarma PD, Behera D. Seizures with single therapeutic dose of isoniazid. Indian Journal of Tuberculosis. 2012; 59: 100-102. doi: PMID: 22838208.
  41. Idris A, Idris S (2023) Sedative-hypnotic effects of Datura arborea Linn extract in experimental animals. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2023; 3(4): 54-60. doi: 10.5281/zenodo.10288346

Submitted date:
10/15/2025

Reviewed date:
10/24/2025

Accepted date:
09/30/2025

6907a79aa9539563e546ece8 mjpe Articles
Links & Downloads

Mediterr J Med Res

Share this page
Page Sections